Why SOLV rose 11% since Oct 30
Up 11% from Oct 30 to Nov 10.
“GAAP and adjusted gross margin both increased, primarily driven by portfolio optimization, mix benefits and savings programs, partially offset by inflation and tariffs.”
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Up 11% from Oct 30 to Nov 10.
“GAAP and adjusted gross margin both increased, primarily driven by portfolio optimization, mix benefits and savings programs, partially offset by inflation and tariffs.”
| The company | A $156M profit |
| Latest filing | 8-K, Nov 5 |
After its last 4 reports it closed -0.6% on average, higher 2 of 4 times.
Excellentfor quality, not price, 6 of 14 chart checks firingWhat the Quality Score means
Well above its recent run. SOLV scores 15 today, against a median of 10 over its last 20 recorded sessions.
SOLV is #11 of 84 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 11 |
Net income over four quarters: SOLV $156M, MMM $3.54B, BDX $941M, MDLN $883M.
Expected to report Thu Feb 25, after the close (in 107 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
Sales of $1.9B, 7% less than a year ago; a loss of $0.07 a share, from a profit of $7.22.
“Organic sales decline of 2.8% in the quarter reflects the expected 630 bps reversal of Q2 2026 advance orders placed ahead of the planned ERP system cutover during Q3 2026.”
| Line | Q3 2026 | Q2 2026 | Q3 2025 |
|---|---|---|---|
| Product | $1.4B | $1.7B | $1.6B |
Each quarter's sales and their share of its total. Figures as filed (SEC filing, Nov 5)
| Measure | Figure |
|---|---|
| Adjusted EPS | $7.20 to $7.30 |
“GAAP and adjusted gross margin both increased, primarily driven by portfolio optimization, mix benefits and savings programs, partially offset by inflation and tariffs.”
From its results filing (SEC filing · Nov 5)
Sales grew 0.8% a year over 3 years, fiscal 2022 to 2025.
Its share count grew 0.5% a year over 3 years.
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Nov 5, 2026 | -0.8% | +3.7% | not yet |
| Aug 5, 2026 | +2.4% | -5.2% | -2.5% |
| May 5, 2026 | -1.5% | +2.8% | +8.8% |
Sales grew every year from 2022 to 2025, to $8.3B. It made a profit in each of the four years.
RSI 58.4, MACD above signal, above both averages. Not scored.
4 trades disclosed in the last six months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: SOLV is under 0.1% of IVV, under 0.1% of SPY, and under 0.1% of VOO, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026 (SPY's as filed by IVV).
In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments. The smallest one—purification and filtration—has since been sold. Now, medsurg is the largest business, contributing roughly 64% of consolidated revenue, and includes advanced wound care and wound prevention. Dental solutions (restorative composites and orthodontia) and health information systems (mainly revenue cycle management) each contribute 18% of total revenue.
“We operate in highly competitive markets across our segments and product categories throughout the world.”
SOLV scores 15 today, which Breakaway calls Excellent. It is #11 of 84 in Medical Devices by Quality Score, with 6 of 14 chart checks firing. Up 11% from Oct 30 to Nov 10. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
SOLV scores 15 today, which Breakaway calls Excellent (15 to 19). That is #11 of 84 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind SOLV's 15.
Expected to report Thu Feb 25, after the close, a date Breakaway expects from the company's usual timing; the company has not confirmed it. SOLV closed higher after 2 of its last 4 reports. Past behavior, not a forecast.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Thursday morning. No account. No card. Then keep going with a free account.